Lazard vs Moelis &

Lazard and Moelis are two prominent financial advisory firms that specialize in mergers and acquisitions, restructuring, and capital raising services. Both firms have cultivated a reputation for providing strategic advice and generating value for their clients. When it comes to their stocks, Lazard and Moelis have shown resilience and growth potential, attracting investors looking to capitalize on the dynamic global deal-making landscape. By examining their financial performance, market positioning, and growth prospects, investors can make informed decisions on investing in Lazard vs Moelis stocks.

Lazard or Moelis &?

When comparing Lazard and Moelis &, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Lazard and Moelis &.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Lazard has a dividend yield of 3.77%, while Moelis & has a dividend yield of 3.38%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Lazard reports a 5-year dividend growth of -5.26% year and a payout ratio of 112.48%. On the other hand, Moelis & reports a 5-year dividend growth of -9.44% year and a payout ratio of 1349.30%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Lazard P/E ratio at 31.54 and Moelis &'s P/E ratio at 383.87. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Lazard P/B ratio is 10.75 while Moelis &'s P/B ratio is 14.32.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Lazard has seen a 5-year revenue growth of 0.29%, while Moelis &'s is -0.29%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Lazard's ROE at 38.22% and Moelis &'s ROE at 3.70%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $52.21 for Lazard and $69.45 for Moelis &. Over the past year, Lazard's prices ranged from $25.82 to $53.78, with a yearly change of 108.31%. Moelis &'s prices fluctuated between $38.58 and $72.14, with a yearly change of 86.99%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.